Grayscale Files for IPO: Crypto Giant Goes Public
Grayscale Investments files S-1 for NYSE IPO under ticker GRAY, joining crypto companies going public. The firm manages $35B in digital assets including GBTC.
NOTRELOAD AI
Hims & Hers Expands Into Lab Testing to Boost Preventive Care
Hims & Hers Health launches lab testing with Quest Diagnostics, offering affordable biomarker tests and personalized health plans as part of its preventive care expansion.
Repsol Eyes Reverse Merger to List Its Oil & Gas Unit in the U.S.
Repsol is exploring a reverse merger of its upstream business with U.S.-based APA Corp. to accelerate its New York listing plans and expand its energy portfolio.
Verizon to Cut 15,000 Jobs Amid Fierce Competition and Cost Pressures
Verizon plans to cut 15,000 jobs and franchise 200 stores to reduce costs as new CEO Daniel Schulman aims to make the company leaner and regain customers in the competitive telecom market.
FDA Approves Kura's Ziftomenib (Komzifti) for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible NPM1 Mutation
The FDA has approved Komzifti for adults facing difficult-to-treat AML linked to a specific NPM1 gene change.
Outlook ONS-5010 BLA Accepted; FDA Target Date Dec 31, 2025
Outlook Therapeutics' potential new treatment, ONS-5010 (LYTENAVA), is under FDA review following a successful BLA resubmission. The decision is expected by December 31, 2025.